Terms: = Gastric cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
9 results:
1. Expression of foxa1 gene regulates the proliferation and invasion of human gastric cancer cells.
Dai Y; Yang G; Yang L; Jiang L; Zheng G; Pan S; Zhu C
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):161-165. PubMed ID: 34817322
[TBL] [Abstract] [Full Text] [Related]
2. An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
Zewdu R; Mehrabad EM; Ingram K; Fang P; Gillis KL; Camolotto SA; Orstad G; Jones A; Mendoza MC; Spike BT; Snyder EL
Elife; 2021 Apr; 10():. PubMed ID: 33821796
[TBL] [Abstract] [Full Text] [Related]
3. foxa1 promotes proliferation, migration and invasion by transcriptional activating KRT7 in human gastric cancer cells.
Liu BL; Qin JJ; Shen WQ; Liu C; Yang XY; Zhang XN; Hu F; Liu GM
J Biol Regul Homeost Agents; 2019; 33(4):1041-1050. PubMed ID: 31317696
[TBL] [Abstract] [Full Text] [Related]
4. The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through foxa1 destabilization.
Tang DE; Dai Y; Xu Y; Lin LW; Liu DZ; Hong XP; Ou ML; Jiang HW; Xu SH
Carcinogenesis; 2020 Mar; 41(1):56-66. PubMed ID: 31046116
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatic analysis suggests that UGT2B15 activates the Hippo‑YAP signaling pathway leading to the pathogenesis of gastric cancer.
Chen X; Li D; Wang N; Yang M; Liao A; Wang S; Hu G; Zeng B; Yao Y; Liu D; Liu H; Zhou W; Xiao W; Li P; Ming C; Ping S; Chen P; Jing L; Bai Y; Yao J
Oncol Rep; 2018 Oct; 40(4):1855-1862. PubMed ID: 30066917
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of foxa1 inhibits cell proliferation and EMT of human gastric cancer AGS cells.
Lin M; Pan J; Chen Q; Xu Z; Lin X; Shi C
Gene; 2018 Feb; 642():145-151. PubMed ID: 29129808
[TBL] [Abstract] [Full Text] [Related]
7. Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers.
Kim JY; Kim CH; Lee Y; Lee JH; Chae YS
Pathology; 2017 Oct; 49(6):589-595. PubMed ID: 28843920
[TBL] [Abstract] [Full Text] [Related]
8. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract] [Full Text] [Related]
9. [Surgical treatment of esophageal carcinoma with cervical esophagogastrostomy by left thoracic esophagectomy].
Chen MY; Gao ZR; Xu JL; Wu S
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):301-3. PubMed ID: 19563704
[TBL] [Abstract] [Full Text] [Related]
